Featured Research

from universities, journals, and other organizations

Glutamatergic agents show promise for mood, anxiety disorders

Date:
October 6, 2013
Source:
European College of Neuropsychopharmacology (ECNP)
Summary:
Glutamergic agents may one day be used as a novel treatment for mood and anxiety disorders.

Glutamergic agents may one day be used as a novel treatment for mood and anxiety disorders, new research presented at the 26th ECNP Congress suggests.

Related Articles


"Our results suggest the glutamatergic system is a truly viable target for antidepressant Profug development," says Professor Gerard Sanacora, from the Yale School of Medicine, Connecticut, US.

In his talk, Professor Sanacora detailed how he and his team have used animal models to help understand how stress and other mechanisms that can disrupt glutamatergic function can lead to molecular, cellular and behavioural changes in the brain that are characteristic of depression.

He also presented results from a completed phase II trial with a unique non-selective NMDA receptor antagonist.

"We found that drugs that can target glutamate transmission, either by altering release, uptake or receptor activation can prevent or attenuate the cellular and behavioural changes seen in mood disorders," he explains.

In humans, the NMDA receptor antagonist showed a surprisingly rapid antidepressant effect. Importantly, the trial demonstrated the potential ability to dissociate the perceptual and cognitive effects of the NMDA receptor antagonists from the antidepressant effects.

His results also suggest the antidepressant effects can be extended for several weeks with repeated infusions.

In rodent models, the team demonstrated that stress has a major impact on the function of glutamate neurotransmission -- especially glutamate clearance through glial cells -- that appears to be related to behavioural changes.

Professor Sanacora presented a series of preclinical and clinical studies indicating that a novel class of drugs that target components of the glutamatergic neurotransmitter system may produce rapid and robust antidepressant effects.

"There is a rapidly expanding literature suggesting the glutamatergic neurotransmitter system is altered in the brains of individuals suffering with mood disorders," explains Professor Sanacora.

There is also increasing evidence suggesting stress may disrupt normal glutamtergic function in the brain and may be a mechanism contributing to the pathogenesis of several stress-related neuropsychiatric disorders," he adds.

Their research, due to be published in the journal Molecular Psychiatry, adds to this body of evidence.

"First and foremost, our findings suggest the glutamatergic system is a truly viable target for antidepressant drug development," concludes Professor Sanacora.


Story Source:

The above story is based on materials provided by European College of Neuropsychopharmacology (ECNP). Note: Materials may be edited for content and length.


Cite This Page:

European College of Neuropsychopharmacology (ECNP). "Glutamatergic agents show promise for mood, anxiety disorders." ScienceDaily. ScienceDaily, 6 October 2013. <www.sciencedaily.com/releases/2013/10/131006142321.htm>.
European College of Neuropsychopharmacology (ECNP). (2013, October 6). Glutamatergic agents show promise for mood, anxiety disorders. ScienceDaily. Retrieved December 21, 2014 from www.sciencedaily.com/releases/2013/10/131006142321.htm
European College of Neuropsychopharmacology (ECNP). "Glutamatergic agents show promise for mood, anxiety disorders." ScienceDaily. www.sciencedaily.com/releases/2013/10/131006142321.htm (accessed December 21, 2014).

Share This


More From ScienceDaily



More Mind & Brain News

Sunday, December 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Researchers Test Colombian Village With High Alzheimer's Rates

Researchers Test Colombian Village With High Alzheimer's Rates

AFP (Dec. 19, 2014) In Yarumal, a village in N. Colombia, Alzheimer's has ravaged a disproportionately large number of families. A genetic "curse" that may pave the way for research on how to treat the disease that claims a new victim every four seconds. Duration: 02:42 Video provided by AFP
Powered by NewsLook.com
Double-Amputee Becomes First To Move Two Prosthetic Arms With His Mind

Double-Amputee Becomes First To Move Two Prosthetic Arms With His Mind

Buzz60 (Dec. 19, 2014) A double-amputee makes history by becoming the first person to wear and operate two prosthetic arms using only his mind. Jen Markham has the story. Video provided by Buzz60
Powered by NewsLook.com
Prenatal Exposure To Pollution Might Increase Autism Risk

Prenatal Exposure To Pollution Might Increase Autism Risk

Newsy (Dec. 18, 2014) Harvard researchers found children whose mothers were exposed to high pollution levels in the third trimester were twice as likely to develop autism. Video provided by Newsy
Powered by NewsLook.com
Yoga Could Be As Beneficial For The Heart As Walking, Biking

Yoga Could Be As Beneficial For The Heart As Walking, Biking

Newsy (Dec. 17, 2014) Yoga can help your weight, blood pressure, cholesterol and heart just as much as biking and walking does, a new study suggests. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins